OPT

Opthea Ltd (OPT)

US
$ 3.07-3.15%

Price Chart

Key Statistics

Market Cap
$ 524.82M
P/E Ratio
0.00
Revenue (TTM)
$ 208.86K
Volume
15.16K
52W High
$ 6.30
52W Low
$ 1.79
Dividend Yield
0.00%
Beta
1.59

Technicals

50-Day MA
4.0165
200-Day MA
3.6124
52 Week High
6.3
52 Week Low
1.79

About OPT

Opthea Limited, a clinical-stage biopharmaceutical company, develops and commercializes drugs for eye diseases in Australia and the United States. Its development activities are based on the intellect.

Employees
33
Headquarters
South Yarra, VIC
CEO
Dr. Frederic Guerard M.S., Pharm.D.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg